Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Curevac N.V.
(NQ:
CVAC
)
2.650
+0.130 (+5.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Curevac N.V.
< Previous
1
2
3
4
5
6
Next >
CVAC Stock: The Huge Covid-19 News That Has CureVac Plunging Today
June 17, 2021
CureVac shares crashed after the German biotech said its Covid-19 vaccine was only 47% effective in preventing the disease.
Via
InvestorPlace
Exposures
COVID-19
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
June 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...
Via
Benzinga
Exposures
COVID-19
25 Stocks Moving in Thursday's Pre-Market Session
June 17, 2021
Gainers Midatech Pharma plc (NASDAQ: MTP) rose 42.2% to $2.90 in pre-market trading after the company disclosed breakthrough data using Q-Sphera technology. Cellect...
Via
Benzinga
Why CureVac's Stock Is Trading Higher Today
May 13, 2021
CureVac (NASDAQ:CVAC) shares are trading higher ...
Via
Benzinga
Tesla-Backed CureVac Plunges On Underwhelming COVID-19 Vaccine Efficacy Data
June 17, 2021
German vaccine developer, CureVac N.V. (NASDAQ: CVAC), may not be as fortunate as its domestic peer BioNTech SE (NASDAQ: BNTX), which along with its...
Via
Benzinga
Exposures
COVID-19
Unusual Options Activity Insight: CureVac
June 16, 2021
CureVac (NASDAQ:CVAC) shares experienced unusual options activity on Wednesday. The stock price moved up to $99.74 following the option alert. Sentiment: BULLISH Option Type:...
Via
Benzinga
Moderna, BioNTech Pop Despite Mounting Pressure On Covid Vaccine Patents
June 10, 2021
The World Trade Organization is moving ahead with a plan that could waive Covid vaccine patents. But vaccine stocks weren't rattled Thursday.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
Mid-Morning Market Update: Markets Mixed; Thor Industries Beats Q3 Estimates
June 08, 2021
Following the market opening Tuesday, the Dow traded down 0.16% to 34,574.38 while the NASDAQ rose 0.32% to 13,926.79. The S&P also fell, dropping 0.04% to 4,224.95. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
75 Biggest Movers From Yesterday
June 09, 2021
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock. NextDecade...
Via
Benzinga
Could CureVac Be a Millionaire-Maker Stock?
June 08, 2021
This biotech's coronavirus vaccine candidate could be the next to hit the market -- but a lot of its potential success has been priced in.
Via
The Motley Fool
Exposures
COVID-19
50 Stocks Moving In Tuesday's Mid-Day Session
June 08, 2021
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares jumped 72.4% to $20.55 amid increased retail investor interest in the stock. NextDecade Corporation (NASDAQ: NEXT...
Via
Benzinga
CureVac's COVID-19 Vaccine Is Safe, But Efficacy Not Yet Disclosed
June 01, 2021
CureVac BV (NASDAQ: CVAC) said its first-generation COVID-19 vaccine candidate had passed its first interim analysis, but it was not yet ready to share efficacy data....
Via
Benzinga
Exposures
COVID-19
The Battle Over Covid Vaccine Patents Begins — What It Could Mean For Biotech
May 20, 2021
Experts say a patent waiver for coronavirus shots wouldn't just pressure Covid vaccine stocks, it could also staunch innovation for biotech companies.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
CureVac-GSK's Second-Gen COVID-19 Vaccine Candidate Shows Encouraging Action Against Variants In Animal Study
May 13, 2021
CureVac N.V. (NASDAQ: CVAC) and GlaxoSmithKline Plc (NYSE: GSK) have released positive early data from a preclinical study of its second-...
Via
Benzinga
Exposures
COVID-19
What's Up WIth BioNTech Stock And CureVac Stock Today?
May 10, 2021
BioNTech SE - ADR (NASDAQ: BNTX) shares were trading higher by 8.27% at $198.80 in Monday’s premarket session after the company announced a Chinese joint venture to...
Via
Benzinga
70 Biggest Movers From Friday
May 10, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1...
Via
Benzinga
Week In Review: WHO Close To Approving Global Use For Two China COVID-19 Vaccines
May 08, 2021
The World Health Organization approved Sinopharm's COVID-19 vaccine for emergency use, which will give poorer nations access to a vaccine against the pandemic. Sinovac's inactivated COVID-19 vaccine...
Via
Talk Markets
Exposures
COVID-19
56 Stocks Moving In Friday's Mid-Day Session
May 07, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....
Via
Benzinga
32 Stocks Moving in Friday's Pre-Market Session
May 07, 2021
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) shares rose 44.2% to $0.7190 in pre-market trading after the company reported better-than-expected Q1 results. iBio, Inc. (NYSE:...
Via
Benzinga
Bill And Melinda Gates' Divorce News A Bull Case For GameStop? What You Need To Know
May 04, 2021
A post by a member of the Reddit investor forum r/GME in March that speculated billionaires were increasing their short positions in GameSt...
Via
Benzinga
CureVac's Vaccine Might Protect Against the South African Variant
May 01, 2021
The promising data in mice needs to translate into humans.
Via
The Motley Fool
Exposures
COVID-19
Could These 3 Brilliant mRNA Stocks Make You Millions?
April 30, 2021
Probably not, but at least one of them could make you thousands over time.
Via
The Motley Fool
Exposures
COVID-19
Best Biotech Stocks & ETFs for mRNA, Gene Editing
April 29, 2021
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
Via
Talk Markets
CureVac's Potential Has Wall Street Sending Mixed Signals
April 26, 2021
The biotech still has a long way to go to prove itself and justify its current stock valuation.
Via
The Motley Fool
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2021
April 26, 2021
Upgrades Susquehanna upgraded the previous rating for Axalta Coating Systems Ltd (NYSE:AXTA) from Neutral to Positive. The current stock performance of Axalta Coating Sys...
Via
Benzinga
2 Reasons This COVID Vaccine Latecomer Could Gain Major Market Share
April 21, 2021
A big market is in big need of more vaccines.
Via
The Motley Fool
Exposures
COVID-19
7 Health Care Stocks Showing Unusual Options Activity In Today's Session
April 19, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
CureVac (CVAC) Q4 2020 Earnings Call Transcript
April 15, 2021
CVAC earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why PPD, Immunic, Inovio and CureVac Shares Are Higher Today
April 15, 2021
PPD, Inc. (NASDAQ: PPD), Immunic, Inc. (NASDAQ: IMUX), Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and CureVac N.V. (NASDAQ: CVAC) are among the healthcare movers on Thursday. PPD...
Via
Benzinga
22 Stocks Moving in Thursday's Pre-Market Session
April 15, 2021
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) rose 25.1% to $0.6485 in pre-market trading. Bit Digital, Inc. (NASDAQ: BTBT) rose 15.1% to $16.40 in pre-market trading after...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.